Fundraising FoxNextech Invest — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
BiotechBurlingame, US
Mark Rolfe(Executive Officer)Laura Shawver(Executive Officer, Director)inTimothy Smith(Executive Officer)
BoardPeter Thompson(Director)inCarol Gallagher(Director)in
Board seatAlfred Scheidegger· per SEC Form D
Co-investorsAstellas Venture Management LLCNew Enterprise Associates (NEA)OUP (Osage University Partners)5AM VenturesClarus VenturesOrbiMed+1 more
Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).
BiotechHealthtechCambridge, US
MICHAEL J. KAUFMAN(Executive Officer)inDonald Bergstrom(Executive Officer)inANNA PROTOPAPAS(Executive Officer, Director)Timothy Lowinger(Executive Officer)Eva Jack(Executive Officer)Wayne Foster(Executive Officer)
Co-investorsBain Capital Life SciencesF-Prime CapitalLightstone VenturesNew Enterprise Associates (NEA)Pfizer Venture InvestmentsRho Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.